Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app)
CA 2380428 A1 · Owner: Allinquant, Bernadette · Inventors: Prochiantz, Alain; Allinquant, Bernadette
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns novel uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (APP); said peptides are in particular sequences including the membrane domain juxtaposed to the cytoplasmic domain of the amyloid protein precursor (APP) (one-letter code) selected in the group consisting of the sequences Y¿1?KQYTSIHHGY¿0? (SEQ ID NO:2) Y¿1?KKQYTSIHHGY¿0? (SEQ ID NO:3) and Y¿1?KKKQYTSIHHGY¿0? (SEQ ID NO:4) wherein Y¿0? is nil or represents V, VV VVE, VVEV or VVVED and Y¿1? represents an internalisation and addressing peptide derived from the 3?rd¿ helix of homeodomains and structurally related peptides. The invention also concerns the use of a peptide …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 28, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 28, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 28, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.